Back
Sigma Lithium Corp. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Sell
46
SGML
Sigma Lithium Corp.
Last Price:
$10.49
Seasonality Move:
9.28%
Sell
30
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.72
Seasonality Move:
-20.14%
Sell
46
Sigma Lithium Corp. (SGML)
is a Sell
Is Sigma Lithium Corp. a Buy, Sell or Hold?
-
The current Sigma Lithium Corp. [SGML] share price is $9.43. The Score for SGML is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
SGML is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.50. The Score for INKT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SGML Stock Price Chart
What is Sigma Lithium Corp.'s stock price today?
-
The Sigma Lithium Corp. share price today is $9.43Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SGML is experiencing selling pressure, which indicates risk of future bearish movement.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
SGML Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 56.07 | Buy |
| Chaikin Money Flow: | -2891114 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.74 - 10.3) | Buy |
| Bollinger Bands (100): | (5.22 - 8.18) | Buy |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 45.24 | Sell |
| Chaikin Money Flow: | -20001 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.92 - 13.34) | Sell |
| Bollinger Bands (100): | (12.18 - 16.64) | Sell |
SGML Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.41 | Sell |
| 20-day SMA: | 8.68 | Buy |
| 50-day SMA: | 7.3 | Buy |
| 200-day SMA: | 7.25 | Buy |
| 8-day EMA: | 9.99 | Sell |
| 20-day EMA: | 9.03 | Buy |
| 50-day EMA: | 7.75 | Buy |
| 200-day EMA: | 7.88 | Buy |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.15 | Buy |
| 20-day SMA: | 11.81 | Sell |
| 50-day SMA: | 13.28 | Sell |
| 200-day SMA: | 11.74 | Sell |
| 8-day EMA: | 11.36 | Buy |
| 20-day EMA: | 11.8 | Sell |
| 50-day EMA: | 12.83 | Sell |
| 200-day EMA: | 12.22 | Sell |
Sigma Lithium Corp. Earnings Growth & SGML Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.32 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Sigma Lithium Corp. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||